동물용 항균제 감수성 검사 시장 : 제품 유형, 동물 유형, 최종사용자별 - 세계 예측(2025-2030년)

The Veterinary Antimicrobial Susceptibility Testing Market was valued at USD 104.59 million in 2023, expected to reach USD 113.38 million in 2024, and is projected to grow at a CAGR of 8.50%, to USD 185.19 million by 2030.

Veterinary Antimicrobial Susceptibility Testing (VAST) is integral to diagnosing and managing infectious diseases in animals, facilitating the correct use of antimicrobials, and mitigating the spread of antimicrobial resistance (AMR). The necessity of VAST arises from the pressing need to ensure animal health and welfare, safeguard public health, and manage antimicrobial efficacy amid escalating AMR concerns. It finds applications in clinical settings, agricultural practices, and research institutions, primarily focusing on livestock, companion animals, and aquaculture. Insights into market growth are driven by increasing animal health awareness, innovation in diagnostic technologies, and regulatory policies advocating for responsible antimicrobial use. The advent of molecular diagnostic technologies, enhancing the speed and precision of susceptibility testing, is a significant contributor to market expansion. Moreover, the growing privatization of veterinary services and the rise in pet ownership worldwide are bolstering demand. However, notable limitations include high costs of testing equipment and processes, especially for small-scale operators, and a lack of standardization in testing procedures globally. Additional challenges stem from the complexity of AMR patterns and the limited availability of updated regional susceptibility data. Despite these challenges, there are promising opportunities in developing rapid, cost-effective point-of-care testing solutions and integrated data management systems that enhance diagnostic efficiency and antimicrobial stewardship. To seize these prospects, stakeholders should invest in R&D for automated and miniaturized testing platforms and collaborate on global initiatives for harmonizing susceptibility testing methodologies. Innovation areas include advancing nanotechnology in diagnostics and leveraging artificial intelligence for predictive analytics in antimicrobial usage patterns. The VAST market is dynamic, characterized by technological advancements and regulatory influences. Stakeholders who strategically align their operations with evolving industry standards and technological progress can secure a competitive edge and contribute meaningfully to global antimicrobial management efforts.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Antimicrobial Susceptibility Testing Market

The Veterinary Antimicrobial Susceptibility Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of companion animal and livestock ownership
  • Rising mortality and disease rates in farm animals
  • Government initiatives to develop national strategy to address antimicrobial resistance
• Market Restraints
  • Lack of efficiency and higher cost in terms of equipment and materials
• Market Opportunities
  • Technological advances in veterinary antimicrobial susceptibility testing
  • Increasing strategic alliances and investments by vendors
• Market Challenges
  • Large inter-individual differences in pharmacokinetic profiles

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Antimicrobial Susceptibility Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Antimicrobial Susceptibility Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Antimicrobial Susceptibility Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Antimicrobial Susceptibility Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Antimicrobial Susceptibility Testing Market

A detailed market share analysis in the Veterinary Antimicrobial Susceptibility Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Antimicrobial Susceptibility Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Antimicrobial Susceptibility Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Antimicrobial Susceptibility Testing Market

A strategic analysis of the Veterinary Antimicrobial Susceptibility Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Antimicrobial Susceptibility Testing Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bioguard Corporation, BioMerieux S.A., Bruker Corporation, FASTinov S.A., Hardy Diagnostics, Himedia Laboratories, IDEXX Laboratories, Inc., LABORATORIOS CONDA, S.A., Liofilchem S.r.l., Mast Group Ltd., Neogen Corporation, SSI Diagnostica A/S, Synoptics Ltd, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Antimicrobial Susceptibility Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Accessories & Consumables, Automated Ast Instruments, Culture Media, and Disks & Plates.
• Based on Animal Type, market is studied across Companion Animals and Food-Producing Animals.
• Based on End-user, market is studied across Veterinary Reference Laboratories and Veterinary Research Institutes & Universities.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of companion animal and livestock ownership
    • 5.1.1.2. Rising mortality and disease rates in farm animals
    • 5.1.1.3. Government initiatives to develop national strategy to address antimicrobial resistance
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of efficiency and higher cost in terms of equipment and materials
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advances in veterinary antimicrobial susceptibility testing
    • 5.1.3.2. Increasing strategic alliances and investments by vendors
  • 5.1.4. Challenges
    • 5.1.4.1. Large inter-individual differences in pharmacokinetic profiles
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Antimicrobial Susceptibility Testing Market, by Product

• 6.1. Introduction
• 6.2. Accessories & Consumables
• 6.3. Automated Ast Instruments
• 6.4. Culture Media
• 6.5. Disks & Plates

7. Veterinary Antimicrobial Susceptibility Testing Market, by Animal Type

• 7.1. Introduction
• 7.2. Companion Animals
• 7.3. Food-Producing Animals

8. Veterinary Antimicrobial Susceptibility Testing Market, by End-user

• 8.1. Introduction
• 8.2. Veterinary Reference Laboratories
• 8.3. Veterinary Research Institutes & Universities

9. Americas Veterinary Antimicrobial Susceptibility Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Veterinary Antimicrobial Susceptibility Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Veterinary Antimicrobial Susceptibility Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Becton, Dickinson and Company
• 2. Bio-Rad Laboratories, Inc.
• 3. Bioguard Corporation
• 4. BioMerieux S.A.
• 5. Bruker Corporation
• 6. FASTinov S.A.
• 7. Hardy Diagnostics
• 8. Himedia Laboratories
• 9. IDEXX Laboratories, Inc.
• 10. LABORATORIOS CONDA, S.A.
• 11. Liofilchem S.r.l.
• 12. Mast Group Ltd.
• 13. Neogen Corporation
• 14. SSI Diagnostica A/S
• 15. Synoptics Ltd
• 16. Thermo Fisher Scientific Inc.